Diego Cadavid to present at 149th Annual Meeting of the American Neurological Association

Don’t miss Verge CMO, Diego Cadavid's presentation on our PIKfyve inhibitor VRG50635 at ANA2024 next week! VRG50635, a potential treatment for ALS, is a major milestone being one of the first drugs discovered and developed from an AI-powered platform to go to clinic. Don’t miss the opportunity to learn more!

We look forward to connecting and discussing the future of drug discovery.